-
1986 Yugo GT with 121 Miles Listed for Sale on Bring a Trailer
-
Ukrainian MP Oleksiy Kucherenko Accidentally Exposes Himself During Live TV Interview
-
Malta Stuns Sweden with Late Penalty Comeback in Rugby Europe Trophy
-
Canva Craft vs ChatGPT: Head-to-Head AI Image Generation Test
-
BingX: Major Announcement of Far-Reaching Significance
-
KFF Health News Reporters Discuss ACA Enrollment Challenges, Rising Costs, and Measles Risks
-
Dell Announces AI-Integrated PC Lineup for 2026 with Wi-Fi 7 Support
-
New to The Street Show #780 Premieres Tonight on Bloomberg Television with Robo.ai, American Fusion, Stewards Investment Capital and FreeCast
-
Gabriel Announces Dismissal of ICSID Annulment Application
SFWJ / Medcana Announces Strategic Expansion Into Australia With Acquisition of Cannabis Import and Distribution Licenses
AUSTIN, TX / ACCESS Newswire / April 19, 2025 / Software Effective Solutions Corp. (OTC:SFWJ), doing business as Medcana, today announced it is proceeding with the acquisition of pharmaceutical cannabis licenses to import and distribute cannabis in Australia.
This move marks a significant milestone in Medcana's global growth strategy. By entering the Australian market, Medcana further strengthens its international footprint in the medical cannabis industry and enhances its global capabilities in both production and distribution of pharmaceutical-grade cannabis products.
The acquired licenses will allow Medcana to import high-quality, research-driven cannabis products into Australia and establish distribution partnerships to meet the growing demand for medical cannabis in the region.
José Gabriel Díaz, CEO of Medcana, commented:
"This is a pivotal step forward for Medcana. Expanding into Australia is not only a strategic decision-it solidifies our position as a global player in the medical cannabis sector. With operations now reaching into Latin America and the Asia-Pacific region, we're uniquely positioned to lead the international supply chain for pharmaceutical cannabis."
About Medcana
Medcana is a U.S.-based public company operating in the international medical cannabis sector. Through its Colombian operations and strategic partnerships, Medcana is focused on the production, research, and global distribution of high-quality pharmaceutical-grade cannabis products.
For investor relations or media inquiries, please contact:
[email protected]
http://www.medcana.co/
Twitter: @MedcanaCo
SOURCE: Software Effective Solutions
View the original press release on ACCESS Newswire
P.A.Mendoza--AT